Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections.
Med Mal Infect
; 50(4): 313-315, 2020 Jun.
Article
in En
| MEDLINE
| ID: mdl-31623961
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Beta-Lactamases
/
Carbapenems
/
Enterobacteriaceae
/
Beta-Lactamase Inhibitors
/
Piperacillin, Tazobactam Drug Combination
/
Anti-Bacterial Agents
Type of study:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Med Mal Infect
Year:
2020
Document type:
Article